Start the right conversation

Bring your question. We’ll connect the right route.

Whether you bring targeting biology, capital, scientific expertise or talent, start with a focused, non-confidential introduction.

01 — Choose your route

One platform. Different conversations.

GenLumina separates pharmaceutical partnering, financing, scientific collaboration and general enquiries. Choose the route that best matches your role.

Pharma & biotech

Partnering

Combine your antibody, peptide or ligand with GenLumina’s light-activated payload platform in a focused, separately financed programme.

Research & translation

Scientific collaboration

Discuss conjugation, tumour models, in-vivo validation, light delivery or translational research around controllable payload activation.

People & communication

Careers, media & general

Interested in joining GenLumina, following our progress, covering our work or asking a general company question?

02 — A focused first step

Start small. Decide what deserves depth.

The first conversation is exploratory and non-confidential. If there is a credible fit, we define the appropriate next step and documentation together.

01

Introduce the opportunity

Tell us what you bring, what you want to evaluate and why GenLumina may be relevant.

02

Confirm strategic fit

We align the scientific, financing or organisational question with the right route.

03

Define the next step

Where appropriate, we agree on confidentiality, documentation, a work package or follow-up meeting.

Not sure where to start?

Send a short non-confidential introduction or book a conversation. We will direct it to the right route.

Visit us
Building – BioPartner 5
De Limes 7
2342 DH Oegstgeest
The Netherlands
Direct

g.kanbier@genlumina.com
Schedule a conversation ↗

Follow

GenLumina on LinkedIn ↗
Company news →

This page is intended for exploratory, non-confidential contact. Please do not send confidential, patient-identifiable or commercially sensitive information before appropriate arrangements are in place.